Company Profiles

driven by the PitchBook Platform

C2 Therapeutics

C2 Therapeutics
2007 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of hospital equipment and supplies. The company provides ablation therapies to improve treatment of precursors to esophageal cancer. Its flagship product is Coldplay Focal Cryoballoon Ablation System, a device involving a balloon catheter that conforms to the shape of the esophageal lumen.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-Backed
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Parent Company
PENTAX Medical
Primary Office
303 Convention Way
Suite 1
Redwood City, CA 94063
United States

+1 (866) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore C2 Therapeutics’s full profile, request a free trial.

C2 Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 09-Jan-2017 000.00 Completed Generating Revenue
4. Convertible Debt 06-Dec-2016 00.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C1) 10-Oct-2014 000.00 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 29-Mar-2012 $2.34M $5.36M 000.00 Completed Startup
1. Early Stage VC (Series A) 16-Jun-2009 $3.02M $3.02M 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

C2 Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C2 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A2 1,188,120 $0.001000 $0.06 $0.18 $0.18 1x $0.18 3.39%
Series A1 6,226,806 $0.001000 $0.06 $0.72 $0.72 1x $0.72 17.79%
To view this company’s complete Cap Table, request access »

C2 Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
De Novo Ventures Venture Capital Minority 000 0000 000000 0
Main Line Equity Partners PE/Buyout Minority 000 0000 000000 0
Synergy Ventures Venture Capital Minority 000 0000 000000 0

C2 Therapeutics Executive Team (7)

Name Title Board
Seat
Contact
Info
Peter Garcia-Meza Co-Founder, President & Chief Executive Officer
Rick Williams Chief Operating Officer
Linda Raggi Vice President, Finance
Lisa Bichsel Vice President, Marketing
Theresa Brandner Vice President, Regulatory and Quality

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com